Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|April 21, 2026
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphomaSarah Dingli, Paul Rothweiler, Andre De Menezes Silva Corraes, et al.
American Journal of Hematology|May 20, 2026
Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World AnalysisMurali Janakiram, Carlyn R Tan, Hira Mian, et al.
Blood Cancer Journal|December 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myelomaKenneth J C Lim, Melinda Tan, Ricardo Parrondo, et al.
American Journal of Hematology|June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple MyelomaKenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Blood Cancer Journal|April 2, 2025
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group StudyCarlyn Rose Tan, Sireesha Asoori, Chiung-Yu Huang, et al.
Blood Cancer Journal|March 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapyJoselle Cook, Supriya Gupta, Nadine Abdallah, et al.
Blood Advances|April 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis (IEC-EC) following ciltacabtagene autoleucelKenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen, et al.
Blood Advances|February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World AnalysisCarlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Blood Advances|August 28, 2025
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell LeukemiaGliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, et al.
Blood Cancer Journal|October 16, 2024
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myelomaGliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, et al.
Pageof 2